Brassica Protection Products get FDA no objection for truebroc Glucoraphanin GRAS status

- Last updated on GMT

The US Food and Drug Administration (FDA) has no objections regarding the generally recognized as safe (GRAS) status of Brassica Protection Products LLC’s truebroc brand of glucoraphanin in food applications.

“The successful review of our GRAS dossier for truebroc reaffirms all of the time, extensive research and testing we dedicate to demonstrating the product’s safety,”​ said Tony Talalay, CEO of Brassica Protection Products. “Notably, the GRAS dossier featured a complete review of the safety of our water-extraction production process from field to finished product. We look forward to promoting the health benefits and safety profile of truebroc to food, beverage and supplement manufacturers who want to add glucoraphanin to their consumer products.”

In December 2013, Brassica submitted its GRAS Notification​ to the FDA with guidance from Spherix Consulting, a division of ChromaDex.

“The independent expert panel we convened in 2013 carefully reviewed and evaluated the publicly available information about glucoraphanin from broccoli seeds and determined that it is generally recognized to be safe for ingestion at the proposed levels of use,”​ commented Claire Kruger, Ph.D, D.A.B.T., president of Spherix Consulting, Inc. “The successful GRAS Notification adds another level of transparency to the scientific process – reassuring consumers that Brassica’s truebroc is safe.”

The ingredient is a natural source of glucoraphanin – a phytonutrient found in broccoli. Glucoraphanin is the precursor to sulforaphane, a natural inducer of Phase 2 detoxification enzymes. 

Related topics: Suppliers, Botanicals

Related news

Show more

Related products

show more

Related suppliers

Follow us


View more